Showing 7161-7170 of 20895 results for "".
- Some Heroes Wear Spectacles: How US Olympian Stephen Nedoroscik is Raising Awareness About 2 Eye Conditionshttps://reachmd.com/news/some-heroes-wear-spectacles-how-us-olympian-stephen-nedoroscik-is-raising-awareness-about-2-eye-conditions/2467758/The Paris Olympics 2024 is creating a lot of show-stopping moments. One such instance came on July 29 when Stephen Nedoroscik, a US gymnast, aced his pommel horse routine, helping Team USA’s
- Study Finds Early Mental Health Support for Men Diagnosed with Prostate Cancerhttps://reachmd.com/news/study-finds-early-mental-health-support-for-men-diagnosed-with-prostate-cancer/2467757/In a recent study published in the journal Psycho-oncology Mental health screenings must be incorporated in routine prostate cancer diagnoses. The call follows new research that shows men need more support both during and immediately after a diagnosis of prostate cancer. <
- Autism and ADHD Linked to Neighborhood Conditionshttps://reachmd.com/news/autism-and-adhd-linked-to-neighborhood-conditions/2467746/Autistic youth who were born in underserved neighborhoods are more likely to have greater attention deficit hyperactivity disorder (ADHD) symptoms than those born in communities with more resources. This is one finding of a new study led by researchers at the UC Davis MIND Institute
- Annual Science of Skin Event Highlights Empowering Conversations About Chronic Diseaseshttps://reachmd.com/news/annual-science-skin-event-highlights-empowering-conversations-about-chronic-diseases/2467751/Empowering conversations around chronic skin diseases is something AbbVie aims to normalize. The fourth annual Science of Skin event featured a panel of experts and patients who shared insights on managing chronic skin conditions and improving quality of life, and Practical Dermatology was there.
- Scientists Get to the Bottom of COVID’s Worst Pediatric Complicationhttps://reachmd.com/news/scientists-get-to-the-bottom-of-covids-worst-pediatric-complication/2467715/Early in the pandemic, some children fought off COVID with few, if any, symptoms, only to go into organ failure a few weeks later. Most recovered after aggressive treatment, but their sudden illness, dubbed multisystem inflammatory syndrome in children (MIS-C), remained a myster
- New Cardiovascular Risk Tool Could Guide Who Needs Medication for High Blood Pressurehttps://reachmd.com/news/new-cardiovascular-risk-tool-could-guide-who-needs-medication-for-high-blood-pressure/2467724/(Science Photo Library via Getty Images) For years, the question of whether to take medication to lower high blood pressure had been partly answered by a tool that calculated someone's 10-year risk of having a heart attack or stroke.<
- WHO Calls Emergency Committee on Mpox Spreadhttps://reachmd.com/news/who-calls-emergency-committee-on-mpox-spread/2467727/The World Health Organization's chief announced Wednesday he was urgently convening an expert committee to advise on whether the growing mpox outbreak in Africa should be declared an international emergency. Since last September, cases have surged in the Democratic
- FDA Approves New Therapy for Glioma Patients for First Time in Decadeshttps://reachmd.com/news/fda-approves-new-therapy-for-glioma-patients-for-first-time-in-decades/2467708/Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations. Based on evidence from the INDIGO clinical trial, a global phase 3, double-blinded, randomized clinical trial, vorasidenib more than double
- York Researchers Make Breakthrough in Bid to Develop Vaccines and Drugs for Neglected Tropical Diseasehttps://reachmd.com/news/york-researchers-make-breakthrough-in-bid-to-develop-vaccines-and-drugs-for-neglected-tropical-disease/2467722/Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer. The breakthrough, by a team from the Univer
- CAR T Cells in Lupus: Promising Results at EULAR 2024 and Emergence of Chinahttps://reachmd.com/news/car-t-cells-in-lupus-promising-results-at-eular-2024-and-emergence-of-china/2467731/At the recent European Alliance of Associations for Rheumatology (EULAR) 2024 conference, chimeric antigen receptor (CAR) T-cell modalities in autoimmune diseases, including systemic lupus erythematosus (SLE) and lupus nephritis (LN), was featured as a key topic. This modality’